Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2002 April;68(4) > Minerva Anestesiologica 2002 April;68(4):162-5





A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036



PERIOPERATIVE MEDICINE  SMART 2002 Milan, May 29-31, 2002

Minerva Anestesiologica 2002 April;68(4):162-5

language: English

Use of selective opiate receptor inhibitors to prevent postoperative ileus

O. Akça, A. G. Doufas *, D. I. Sessler **

From the Neurosciences ICU Outcomes Research® Institute
*Department of Anesthesiology University of Louisville Louisville, KY, USA
**Associate Dean of Research Director Outcomes Research® Institute Distinguished University Research Chair Lolita and Samuel Weakley Professor of Anesthesiology
University of Louisville Professor and Vice-Chair Ludwig Boltzmann Institute, University of Vienna, Vienna, Austria


Ileus is a common postoperative complication after major abdominal surgery. Surgical manipulation of the bowel and stimulation of opiod receptor are the main causes of ileus. An investigational drug (ADL 8-2698, Alvinopam) a selective opioid antagonist with a very low oral absorption was recently introduced to clinical medicine. Unlike other opioid antagonist its activity is restricted to GI tract, it is potent, has a long duration of action, is orally effective, does not readily cross the blood-brain barrier even after intravenous administration in animals.
Two randomized controlled clinical studies tested its effects in humans.
Liu et al.’s study confirmed peripheral restriction of ADL 8-2698 by its lack of central effect on morphine analgesia and pupil miosis. They also showed that ADL 8-2698 prevents increases in gastrointestinal transit time.
Taguchi et al. concluded that high dose (6 mg) of ADL 8-2698 archived fast recovery of gastrointestinal function, without antagonising analgesic efficacy of systemic opioid.
In summary, selective inhibition of gastrointestinal opioid receptor by a peripherally restricted oral antagonist speeds recovery of bowel function, shortens times of hospitalization and preserves the analgesic effects of opiods.

top of page

Publication History

Cite this article as

Corresponding author e-mail